INS and type 2 diabetes mellitus: Current therapeutic strategies for type 2 diabetes are limited and involve insulin and oral antidiabetic agents that stimulate pancreatic insulin secretion, reduce hepatic glucose production, delay digestion and absorption of intestinal carbohydrates, or improve insulin action.